Target intelligence / Profile preview

Postmeiotic segregation increased 2 pseudogene 5 (PMS2P5)

Target
PMS2P5
Molecular classification
Pseudogene, Non-coding RNA, Antisense transcript
01

Overview

Postmeiotic segregation increased 2 pseudogene 5" (PMS2P5, ENSG00000304176) is a non-coding RNA or pseudogene that is antisense to SPDYE12. It is classified as a member of the PMS2 gene family, which is best known for its role in DNA mismatch repair via the canonical PMS2 protein. However, unlike PMS2, PMS2P5 is not known to produce a functional protein and has no established role in DNA repair or any other cellular process. Its annotation as a "novel transcript, antisense to SPDYE12" reflects its genomic location rather than functional significance. There is no evidence that this gene acts as a therapeutic target, nor is there any information linking it to direct drug interactions, disease associations, or functional protein activities[5][7]. Summary: ENSG00000304176 (PMS2P5) is a non-functional pseudogene with no established therapeutic, enzymatic, or receptor activity. It should not be considered a drug target. Its primary significance is as a genomic element related to the PMS2 and SPDYE12 gene regions[5][7].

Other names
PMS2L5PMS7postmeiotic segregation increased 2 pseudogene 5postmeiotic segregation increased 2-like 5PMS2P5ENSG00000304176
02

Biological functions

Other (no known direct biological function; linked to DNA mismatch repair only by sequence similarity to PMS2)
03

Disease associations

Other (no evidence for direct involvement in disease)

Beyond the preview

Go deeper on Postmeiotic segregation increased 2 pseudogene 5 (PMS2P5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Postmeiotic segregation increased 2 pseudogene 5 (PMS2P5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call